Plasma cell CD20 expression: primary aberrant expression or receptor up-regulation

Leuk Lymphoma. 2014 Feb;55(2):444-6. doi: 10.3109/10428194.2013.802782. Epub 2013 Jun 19.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antigens, CD20 / metabolism*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Female
  • Humans
  • Immunohistochemistry
  • Middle Aged
  • Multiple Myeloma / drug therapy
  • Multiple Myeloma / metabolism
  • Plasma Cells / drug effects
  • Plasma Cells / metabolism*
  • Plasma Cells / pathology
  • Up-Regulation*

Substances

  • Antigens, CD20